Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)
Sinicrope, Frank A., Segovia, Diana, Sharma, Nalin , Alberts, Steven R. , Hardin, Aaron , Rich, Thereasa A. , Shi, Qian, Sinicrope, Frank A. , Shi, Qian , Sinicrope, Frank A , Rich, Thereasa , Shi, Qian , Alberts, Steven R , Hardin, Aaron

Mayo Clinic

Journal of Clinical Oncology | January 30, 2026 | Volume: 44 | Issue: 15 | Pages: 1401-1415

10.1200/jco-25-02086 | PMID 41616224 Get It

PURPOSE Detection of molecular residual disease using circulating tumor DNA (ctDNA) may enable postoperative risk stratification and guide adjuvant therapy. We evaluated the prognostic value of a tissue-free, epigenomic ctDNA assay in patients with stage III colon cancer (CC) enrolled in a phase III adjuvant chemotherapy trial. METHODS Plasma samples were collected after surgery and before adjuvant infusional fluorouracil, leucovorin, and oxaliplatin alone or combined with cetuximab. ctDNA was analyzed using a tissue-free assay; in ctDNA-positive patients, tumor fraction (TF) was quantified and genotyping was performed with a 739-gene panel. Associations with disease-free survival (DFS), time to recurrence (TTR), and overall survival (OS) were assessed using multivariable Cox models adjusted for covariates. RESULTS Among 2,260 evaluable patients, 461 (20.4%) were ctDNA-positive with significantly higher detection in advanced T-/N-stage, high-grade, obstruction/perforation, and BRAF V600E tumors. At a median follow-up of 6.1 years, ctDNA positivity was independently associated with shorter TTR (hazard ratio [HR], 5.96 [95% CI, 5.11 to 6.96]), DFS (HR, 5.03 [95% CI, 4.36 to 5.81]), and OS (HR, 4.45 [95% CI, 3.76 to 5.27]; all P < .0001). The 5-year DFS was 27.7% (95% CI, 23.8 to 32.2) v 77.1% (95% CI, 75.1 to 79.1) in ctDNA-positive versus ctDNA-negative patients, and adverse prognostic impact was greater in lower T/N stage, low-risk, and dMMR subsets (interaction P = .0012-.041). Among ctDNA-positive patients, TF was nearly double in those who recurred or died ( P = .0002) and stratified patients for TTR, DFS, and OS (all adjusted P < .002). Genotyping identified mutations in FLT1 (OR, 8.99) and PREX2 (OR, 7.73) genes that were most strongly associated with recurrence ( P < .03). CONCLUSION Evaluation of ctDNA in resected stage III CC using a tissue-free assay provided robust and independent prognostic value. Higher ctDNA burden, dMMR, and specific mutations defined poor prognostic groups among ctDNA-positive patients.
Multi-Targeted TKIs in Patients with Advanced Ewing Sarcoma: A Systematic Review and Single-Arm Meta-Analysis
Michelon, Isabella , Castro, Caio Ernesto do Rego, Belluco, Ana Paula Querino, Dacoregio, Maria Inez , Priantti, Jonathan N. , Witt, Russell G. , Attia, Steven , Vilbert, Maysa , Cavalcante, Ludimila , do Rêgo Castro, Caio Ernesto , Belluco, Ana Paula

Mayo Clinic

Cancers | January 30, 2026 | Volume: 18 | Issue: 3 | Pages: 465

10.3390/cancers18030465 | PMID 41681938 Get It

Background/Objectives: Standard treatment of multiply relapsed Ewing sarcoma remains to be established. Recent studies evaluating tyrosine kinase inhibitors (TKIs) with anti-angiogenic properties have shown encouraging results. Therefore, we conducted a systematic review and meta-analysis to explore the efficacy and safety of TKIs in patients with Ewing sarcoma. Methods: We comprehensively searched PubMed, Embase, and Cochrane databases for clinical trials (CTs) and cohort studies assessing TKIs in the treatment of advanced Ewing sarcoma patients who received at least one prior line of therapy. The main outcome was objective response rate (ORR). All analyses were conducted using R software (v.4.2.2), employing random effects models with 95% confidence intervals (CIs). Results: We included 14 studies (seven phase II CT and seven retrospective cohorts), comprising 257 patients. The following TKIs were evaluated: cabozantinib, regorafenib, apatinib, anlotinib, sorafenib, lenvatinib, sunitinib, fruquintinib, and imatinib. In a pooled analysis of all Ewing sarcoma patients treated with TKIs, the ORR was 23% (95% CI, 11.2–37.1%) and the DCR was 61.1% (95% CI, 47.3–74.2%). Responses were numerically higher but statistically nonsignificant between clinical trials and real-world studies. The analysis including only single-agent TKIs showed better responses for anlotinib and apatinib, yet these drugs are not available in Western countries. Among the FDA-approved TKIs, superior outcomes were noted with single-agent cabozantinib. (ORR: 21.6%) and regorafenib (ORR: 11.3%). Several studies did not report toxicity data exclusively for Ewing sarcoma patients; thus, conclusions about toxicity are mostly based on the general population of studies and may not be fully representative of Ewing sarcoma patients. Conclusions: Anti-angiogenic TKIs have shown important anti-tumoral activity in patients with Ewing sarcoma. Efficacy was consistently seen in both clinical trials and real-world studies. Nonetheless, there are important differences in study design and population that may limit our interpretation of efficacy and toxicity findings.
Biomechanical Evaluation of Safe Incisions to Mitigate Failure in Tendon Repair
HSU, C. Y., Berglund, Lawrence J., Selim, Omar A., Wan, Rou , Moran, Steven Lawrance, Zhao, Chunfeng, Selim, Omar A., Brancaccio, Hanna , Zhao, Chunfeng

Mayo Clinic

Formosan Journal of Musculoskeletal Disorders | January 30, 2026 | Volume: 17 | Issue: 2 | Pages: 88-94

10.4103/fjmd.fjmd-d-25-00035 Get It

Background: Rupture at tendon repair sites in animal models impedes the study of healing. To address this, we investigated “safe incisions” – strategic partial transections to prevent rupture under excessive force. We hypothesized these would act as mechanical “fuses,” reducing repair site tension. Objectives: This in vitro biomechanical study optimized safe incision spacing to enhance tendon construct strength and minimize gap formation in a turkey flexor tendon model. Materials and Methods: Forty turkey flexor tendons were divided into five groups ( n = 8): Repaired without incisions, intact with 5 mm incisions, repaired with 5 mm incisions, intact with 10 mm incisions, and repaired with 10 mm incisions. Repairs used a modified Pennington suture. Safe incisions (opposing hemi-transections) with 5 mm or 10 mm longitudinal spacing were created proximally. Tendons were tested to failure at 1 mm/s, recording force-elongation, failure mode, gap formation (>2 mm at 10% strain), stiffness, and repair site elongation. Results: Repaired tendons without incisions (Group 1) showed 100% repair site failure (46.5 ± 10.96 N). With 5 mm safe incisions (Group 3), no repair site failures occurred (incision failure at 18.11 ± 10.96 N). 10 mm incisions (Group 5) offered partial protection (25% repair failure at 37.48 ± 11.35 N). Group 1 had higher gap formation (75% vs. 0% in Group 3, P < 0.01), stiffness, and repair site elongation than Groups 3 and 5. Gap formation force was similar for Group 1 (25.76 ± 9.18 N) and Group 5 (25.04 ± 12.21 N). Conclusions: In this in vitro model, 5 mm spaced safe incisions effectively shifted failure away from the repair and limited gap formation by reducing stiffness. 10 mm incisions provided partial protection. Strategically placed safe incisions show potential to protect tendon repairs from immediate rupture by enabling controlled lengthening at a weaker site. However, tendinopathy risk and clinical relevance require in vivo studies.
Agent-based large language model system for extracting structured data from breast cancer synoptic reports: a dual-validation study
Hart, S. N., Bergamaschi, Teya S. , Hart, Steven N. , Hart, Steven N

Mayo Clinic

JAMIA Open | January 27, 2026 | Volume: 9 | Issue: 1 | Pages: No page available

10.1093/jamiaopen/ooag016 | PMID 41756715 Get It

Abstract Objectives To develop and validate an agent-based Large Language Model (LLM) system for extracting structured data from breast cancer synoptic pathology reports and assess the performance gap between synthetic and real-world validation. Materials and Methods We developed a modular artificial intelligence (AI) agent-based framework employing sequential specialized LLMs for parsing pathology reports and extracting structured data. We normalized College of American Pathologists (CAP) cancer protocols into 8 sections, 86 subsections, and 229 discrete fields. Seven leading LLMs (gemini-2.5-pro, llama3.3-70b, phi4-14b, deepseek-r1 14B/70B, gemma3-27b, gemini-2.0-flash-lite) were validated using dual evaluation: synthetic validation (864 controlled test cases) and real-world ground truth (6651 annotated fields from 90 pathology reports). Results Synthetic validation demonstrated strong performance (accuracy: 93.8%-99.0%). Real-world evaluation revealed field extraction recall ranging from 61.8% to 87.7%, demonstrating a substantial “reality gap” with performance drops of 11-32 percentage points. The gemini-2.5-pro model achieved the highest real-world recall (87.7%). Model size did not predict performance: the 14B-parameter deepseek-r1 (77.6%) outperformed its 70B-parameter counterpart (70.4%). Discussion The substantial performance degradation from synthetic to real-world data underscores the complexity of authentic clinical documentation. Smaller models can achieve competitive or superior recall, reducing computational costs. With even the best models missing 12%-38% of annotated fields, mandatory human verification is essential for clinical deployment. Conclusion While LLM-based extraction systems show promise for pathology data extraction, synthetic validation alone provides false confidence. Rigorous real-world ground truth evaluation with expert annotation is essential before clinical deployment. These systems are best positioned as screening tools with mandatory human oversight rather than autonomous decision-making systems.
A Phosphorylation Switch Governs KIF11’s Mechanical Output During Mitosis
Šemić, Amila , Reddy, Babu Jn, Muretta, Joseph M. , Vandal, Sarah E. , Thompson, Alex F. , Fonseca, Cindy L., Rosenfeld, Steven S. , Gross, Steven P. , Stumpff, Jason , Reddy, Babu J.N.

Mayo Clinic

No container title available | January 25, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.23.700875 | PMID 41648279 Get It

Abstract The kinesin-5 motor protein KIF11 is crucial for mitotic spindle assembly, driving the separation of spindle poles through microtubule sliding. Src-family kinases phosphorylate KIF11 at multiple tyrosine residues within its motor domain, but the mechanistic consequences of these modifications remain unclear. Here, we dissect the role of phosphorylation at Y211 using phospho-mimetic (Y211E) and non-phosphorylatable mutants (Y211F) in biochemical, biophysical, and cellular assays. Optical trapping and Förster resonance energy transfer (FRET) analyses reveal that Y211 phosphorylation slows neck-linker docking, reducing motor velocity and force generation under load. In human cells, Y211E expression impairs bipolar spindle formation and decreases spindle pole separation velocity, while Y211F shortens steady-state spindle length. Fluorescence recovery after photobleaching (FRAP) analyses show that Y211E accelerates motor turnover on spindle microtubules, consistent with the mutant motor’s heightened load sensitivity. Together, these findings support a model in which Src-mediated phosphorylation at Y211 acts as a rheostat to tune KIF11 mechanochemistry and spindle assembly dynamics, linking cancer-relevant kinase signaling to mitotic force generation.
Practical Interpretation of Bone Scintigraphy: Metastases, Fractures, and Beyond
Haug, Logan P. , Brown, Parker J. , Bishay, Steven , Lombardi, Alecio F. , Huang, Steve S. , Shin, Clifford , Koran, Mary Ellen I. , Long, J. B., Martínez, Felipe Derteano, Nguyen, Ba D. , Long, Jeremiah R. , Bishay, Steven E , Long, Jeremiah , Martinez, Felipe , Nguyen, B D , Koran, Mary Ellen

Mayo Clinic

RadioGraphics | January 15, 2026 | Volume: 46 | Issue: 2 | Pages: No page available

10.1148/rg.250055 | PMID 41538361 Get It

Bone scintigraphy is a valuable adjunct to cross-sectional imaging and can be used to evaluate disease extent in multifocal processes such as blastic osseous metastatic disease, provide diagnostic information to aid in problem solving in challenging cases, and serve as the primary diagnostic modality for diseases that manifest with pathognomonic scintigraphic appearances.
Traumatic Lunate Fracture Patterns and Outcomes of Treatment
Tunaboylu, Mehmet Furkan , Emanuels, Andrew, Loron, Ali Gharibi , Sarcon, Aida K. , Moran, Steven L., Tunaboylu, Mehmet Furkan , Morsy, Mohamed , Moran, Steven L.

Mayo Clinic

Journal of Wrist Surgery | January 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2772-2209 Get It

Abstract The purpose of this study was to evaluate the incidence and outcomes of traumatic lunate fractures in a Level I trauma center over a 20-year period. Traumatic lunate fractures are rare, making it difficult to determine their frequency, outcomes, and patterns in clinical practice. A retrospective evaluation of 57 patients was conducted at a single institution from 2000 to 2022. Imaging studies, including radiographs, computed tomography, and magnetic resonance imaging, were reviewed to confirm traumatic etiology and fracture pattern. Fifty-seven lunate fractures met inclusion criteria: 11 were isolated and 46 had associated carpal fractures. Treatment included immobilization in 31 patients and surgery in 26. At a mean follow-up of 20.5 months (range, 2–186), average wrist flexion–extension range of motion was 90 degrees (range, 45–160), and grip strength averaged 26 kg (range, 6–48). Patient-reported outcomes were collected at a mean of 105 months (range, 12–226), with mean scores of 27 for the Disabilities of the Arm, Shoulder, and Hand, 19 for the Patient-Rated Wrist Evaluation, and 77 for the Mayo Wrist Score. Complications included 25 cases of posttraumatic arthritis, 2 cases each of avascular necrosis (AVN), nonunion, and complex regional pain syndrome, and 1 hardware infection. Posttraumatic arthritis was more frequently observed in patients with dorsal intercalated segment instability (DISI), age over 50 years, and displaced fractures. Lunate fractures occur in conjunction with greater arc injuries. Volar pole fractures were the most common fracture type observed. Predictors of long-term osteoarthritis included age over 50 years, DISI deformity, and displaced fractures at the time of diagnosis. Surgical fixation methods resulted in comparable outcomes. Two lunates progressed to AVN, both of which occurred following open operative fixation. Prognostic, Level IV
The Impact of Capitate Morphology on Scaphoid Flexion in Wrist Kinematics
Hsu, Cheng-En , Vilai, Parunyu , Wan, Rou , Zhao, Chunfeng , Moran, Steven L., Moran, Steven L.

Mayo Clinic

Journal of Wrist Surgery | January 7, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2772-1602 Get It

Abstract Column-type wrists, which exhibit increased scaphoid flexion during radial deviation, often experience greater loss of motion after periscaphoid arthrodesis compared with row-type wrists. Dynamic radiographic series are typically used to differentiate these kinematic patterns. In this study, we evaluate capitate morphology as a means of predicting column- or row-type carpal kinematics. This study investigated whether wrist kinematic patterns could be predicted using simple anteroposterior (AP) radiographs. We hypothesized that capitate morphology, given its close articulation with the scaphoid, influences these patterns. We analyzed 75 wrist motion radiographic series from 45 patients. Capitates were classified as either Type I (rectangular) or Type II (pentagonal) based on their shape. Wrist kinematic patterns were categorized as row- or column-type based on the degree of scaphoid length shortening during radial deviation. Our analysis revealed that a Type II capitate was a significant predictor of column-type wrists, with an odds ratio of 6.01 compared with Type I (p = 0.014). Furthermore, Type II capitates were associated with increased scaphoid flexion and reduced translation. Capitate morphology, as assessed from a plain AP radiograph, can serve as an easily accessible marker and reliable predictor of wrist motion patterns. This could potentially aid in surgical planning and patient counseling, particularly when dynamic radiographic series are not feasible. Diagnostic, Level III.
Purified Exosome Product Enhances Tendon-Bone Healing in a Rat Rotator Cuff Repair Model
Zhao, Gongyin, Tsukamoto, Ichiro, Yousefi, Farbod , Moran, Steven L., Sanchez-Sotelo, Joaquin L., Zhao, Chunfeng, Zhao, Gongyin , Tsukamoto, Ichiro , Sanchez-Sotelo, Joaquin, Moran, Steven L. , Behfar, Atta , Sánchez‐Sotelo, Joaquín , Zhao, Chunfeng

Mayo Clinic

The American Journal of Sports Medicine | January 1, 2026 | Volume: 54 | Issue: 1 | Pages: 162-173

10.1177/03635465251395275 | PMID 41476411 Get It

Background: Tendon-bone healing after rotator cuff injury is, or remains, a clinical challenge. Purpose: To examine the role of intraoperative use of purified exosome products (PEPs) in the treatment of rotator cuff injuries and to assess the effect of PEP on supraspinatus tendon-bone healing after rotator cuff repair in a rat model. Study Design: Controlled laboratory study. Methods: This study used 120 Sprague-Dawley rats that underwent an acute supraspinatus tendon transection from the insertion, followed by repair using a single transosseous suture. They were divided into 3 groups: a control group that received only sutures, a TISSEEL group that used a commercially available fibrin sealant patch (TISSEEL) of approximately 0.5 cm 2 , and a PEP-TISSEEL group that used a similarly sized TISSEEL patch combined with PEP. Autopsies were performed at 1, 3, 6, and 8 weeks after surgery. Analyses were performed using molecular biological, biomechanical, and histological techniques. Results: At 6 weeks, the PEP-TISSEEL group achieved greater failure load (mean, 27.5 ± 5.3 N) than the control (mean, 16.4 ± 4.2 N; P = .012) and TISSEEL (mean, 23.4 ± 5.0 N; P = .041) groups, with superiority persisting at 12 weeks (27.2 ± 6.5 N vs 13.1 ± 2.6 N [ P = .002] for the control group and 21.1 ± 5.8 N [ P = .037] for the TISSEEL group). DigiGait showed earlier recovery of stride length and paw angle. Histology revealed organized collagen and reduced scarring, while molecular assays demonstrated early inflammatory modulation with subsequent upregulation of collagen type 1 or 3 and TGF-β, supporting accelerated tendon-bone healing. Conclusion: Intraoperative application of PEP-TISSEEL enhanced tendon-bone healing in a rat model by improving biomechanical strength, promoting enthesis-specific histological regeneration, and accelerating functional recovery as evidenced by gait analysis. Clinical Relevance: The intraoperative application of PEP combined with TISSEEL significantly enhances rotator cuff tendon healing by modulating early inflammation, promoting collagen synthesis, and improving biomechanical properties in a rat model. These findings suggest that PEP-based therapies could offer a promising adjunct in surgical repair, potentially reducing retear rates and improving functional outcomes in patients with rotator cuff injuries. Further clinical studies are warranted to translate these benefits into human applications.
Risk of rhabdomyolysis with concomitant use of statins and SGLT2 inhibitors: A population‐based cohort study
Awad, Kamal, Mahmoud, Ahmed K., Sheashaa, Hesham, Scalia, Isabel G. , Abdelfattah, Fatmaelzahraa , Razaghi, Mahshad , Mousa, Hana, Lester, Steven J., Arsanjani, Reza, Awad, Kamal , Sheashaa, Hesham , Pietri, Milagros Pereyra, Scalia, Isabel G , Ayoub, Chadi , Awad, Kamal , Mahmoud, Ahmed , Abbas, Mohammed Tiseer , Pereyra, Milagros , Ibrahim, Ramzi , Farina, Juan M. , Arsanjani, Reza

Mayo Clinic

Journal of Internal Medicine | December 22, 2025 | Volume: 299 | Issue: 3 | Pages: 417-419

10.1111/joim.70062 | PMID 41424321 Get It